Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location

Journal of Neuroscience

Volumn 26, Issue 10, 2006, Pages 2788-2797

  Ford, Christopher P ^a   Mark, Gregory P ^b   Williams, John T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

opioid; opioid; Morphine; Retrograde labeling; Ventral tegmental area; Withdrawal

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DOPAMINE; DOPAMINE TRANSPORTER; KAPPA OPIATE RECEPTOR AGONIST; METENKEPHALIN; MICROSPHERE; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL LABELING; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG ABUSE; FEMALE; GABAERGIC TRANSMISSION; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; MEMBRANE CURRENT; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; NERVE PROJECTION; NONHUMAN; NUCLEUS ACCUMBENS; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; REGULATORY MECHANISM; REWARD; VENTRAL TEGMENTUM;

AMYGDALA; ANALGESICS; ANIMALS; BICUCULLINE; BIOTIN; CELL COUNT; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; ELECTRIC STIMULATION; FEMALE; GABA ANTAGONISTS; IMMUNOHISTOCHEMISTRY; LIMBIC SYSTEM; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED DBA; MICROINJECTIONS; MOLECULAR SEQUENCE DATA; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NEURAL INHIBITION; NEURAL PATHWAYS; NEURONS; NUCLEUS ACCUMBENS; PATCH-CLAMP TECHNIQUES; REACTION TIME; SEROTONIN; SEROTONIN AGONISTS; SYNAPTIC TRANSMISSION; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 33644832076     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4331-05.2006     Document Type: Article

References (51)

1. Adell A, Artigas F (2004) The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neurosci Biobehav Rev 28:415-431.
2. Albanese A, Minciacchi D (1983) Organization of the ascending projections from the ventral tegmental area: a multiple fluorescent retrograde tracer study in the rat. J Comp Neurol 216:406-420.
3. Bachtell RK, Whisler K, Karanian D, Self DW (2005) Effects of intranucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat. Psychopharmacology (Berl) 183:41-53.
4. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS (1993) Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264:489-495.
5. Beckstead MJ, Grandy DK, Wickman K, Williams JT (2004) Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 42:939-946.
6. Bonci A, Williams JT (1997) Increased probability of GABA release during withdrawal from morphine. J Neurosci 17:796-803.
7. Brinley-Reed M, McDonald AJ (1999) Evidence that dopaminergic axons provide a dense innervation of specific neuronal subpopulations in the rat basolateral amygdala. Brain Res 850:127-135.
8. Cameron DL, Williams JT (1993) Dopamine D1 receptors facilitate transmitter release. Nature 366:344-347.
9. Cameron DL, Wessendorf MW, Williams JT (1997) A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience 77:155-166.
10. Chefer VI, Czyzyk T, Bolan EA, Moron J, Pintar JE, Shippenberg TS (2005) Endogenous κ-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. J Neurosci 25:5029-5037.
11. Cragg S, Rice ME, Greenfield SA (1997) Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum. J Neurophysiol 77:863-873.
12. Cragg SJ, Nicholson C, Kume-Kick J, Tao L, Rice ME (2001) Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. J Neurophysiol 85:1761-1771.
13. Dalman FC, O'Malley KL (1999) Kappa-opioid tolerance and dependence in cultures of dopaminergic midbrain neurons. J Neurosci 19:5750-5757.
14. Dodt HU, Eder M, Schierloh A, Zieglgansberger W (2002) Infrared-guided laser stimulation of neurons in brain slices. Sci STKE 2002:PL2.
15. Everitt BJ, Dickinson A, Robbins TW (2001) The neuropsychological basis of addictive behaviour. Brain Res Brain Res Rev 36:129-138.
16. Frenois F, Stinus L, Di Blasi F, Cador M, Le Moine C (2005) Aspecific limbic circuit underlies opiate withdrawal memories. J Neurosci 25:1366-1374.
17. Garzon M, Pickel VM (2001) Plasmalemmal mu-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area. Synapse 41:311-328.
18. Geffen LB, Jessell TM, Cuello AC, Iversen LL (1976) Release of dopamine from dendrites in rat substantia nigra. Nature 260:258-260.
19. Grace AA, Onn SP (1989) Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J Neurosci 9:3463-3481.
20. Gysling K, Wang RY (1983) Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res 277:119-127.
21. Hasue RH, Shammah-Lagnado SJ (2002) Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat. J Comp Neurol 454:15-33.
22. Hatfield T, Han JS, Conley M, Gallagher M, Holland P (1996) Neurotoxic lesions of basolateral, but not central, amygdala interfere with pavlovian second-order conditioning and reinforcer devaluation effects. J Neurosci 16:5256-5265.
23. Ikemoto S, Panksepp J (1999) The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev 31:6-41.
24. Joel D, Weiner I (2000) The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96:451-474.
25. Johnson SW, North RA (1992a) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488.
26. Johnson SW, North RA (1992b) Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol (Lond) 450:455-468.
27. B synaptic potential in rat dopamine neurons. J Neurosci 12:2000-2006.
28. Kalivas PW, Duffy P (1991) A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J Neurochem 56:961-967.
29. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
30. Le Moal M, Simon H (1991) Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 71:155-234.
31. Liss B, Haeckel O, Wildmann J, Miki T, Seino S, Roeper J (2005) K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci 8:1742-1751.
32. Margolis EB, Hjelmstad GO, Bonci A, Fields HL (2003) κ-Opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci 23:9981-9986.
33. Maurin Y, Banrezes B, Menetrey A, Mailly P, Deniau JM (1999) Three-dimensional distribution of nigrostriatal neurons in the rat: relation to the topography of striatonigral projections. Neuroscience 91:891-909.
34. h channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J Neurosci 22:1290-1302.
35. Pan ZZ (1998) mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci 19:94-98.
36. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates, Ed 2. Orlando, FL: Academic.
37. Phillips AG, LePiane FG (1980) Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol Biochem Behav 12:965-968.
38. 2 receptors. J Neurosci 22:8002-8009.
39. See RE, Kruzich PJ, Grimm JW (2001) Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology (Berl) 154:301-310.
40. Senatorov VV, Hu B (1998) Unidirectional axonal transport in in vitro adult rat brain explants. Neuroscience 82:59-67.
41. Senatorov VV, Renaud LP (1999) Projections of medullary and pontine noradrenergic neurons to the horizontal limb of the nucleus of diagonal band in the rat. Neuroscience 88:939-947.
42. B-mediated synaptic potentials in the ventral tegmental area during morphine withdrawal. J Neurosci 19:2347-2355.
43. Sugita S, Johnson SW, North RA (1992) Synaptic inputs to GABAA and GABAB receptors originate from discrete afferent neurons. Neurosci Lett 134:207-211.
44. Swanson LW (1982) The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 9:321-353.
45. Ungless MA, Magill PJ, Bolam JP (2004) Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303:2040-2042.
46. White FJ (1996) Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci 19:405-436.
47. Whitelaw RB, Markou A, Robbins TW, Everitt BJ (1996) Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology (Berl) 127:213-224.
48. Williams JT, North RA, Shefner SA, Nishi S, Egan TM (1984) Membrane properties of rat locus coeruleus neurones. Neuroscience 13:137-156.
49. Williams JT, Christie MJ, Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343.
50. Wise RA (1996a) Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19:319-340.
51. Wise RA (1996b) Neurobiology of addiction. Curr Opin Neurobiol 6:243-251.